CMO · CATALYST PHARMACEUTICALS, INC. (CPRX)

William Andrews

FY2025 is the first fiscal year CompBrief holds for William Andrews as a named executive officer of CATALYST PHARMACEUTICALS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$4,130,549

Salary $316,548Stock awards $1,057,998Bonus $208,050

2nd of 5 named executive officers at Catalyst Pharmaceuticals by FY2025 total.

5 named officers on file for CATALYST PHARMACEUTICALS, FY2025

William Andrews’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • CPRX’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how CATALYST PHARMACEUTICALS’s whole pay program stands against its peers

  • CATALYST PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CPRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2026 (10-K/A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get William Andrews’s full pay file as a PDF — free

More than this page: up to 10 years of William’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

William Andrews compensation by year

CATALYST PHARMACEUTICALS Summary Compensation Table · the one fiscal year held
In US dollars, as CATALYST PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$316,548
Bonus$208,050
Stock awards$1,057,998
Option awards$2,537,053
Non-equity incentive$0
Pension and deferred compensation$0
All other$10,900
Total$4,130,549

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CATALYST PHARMACEUTICALS, INC. 10-K/A filed April 30, 2026, accession 0001193125-26-197490, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CATALYST PHARMACEUTICALS, INC. filed document, accession 0001193125-26-197490. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
PSU15,261$0—
PSU29,776$0—
Option124,447—$24.90
Option98,652—$22.77

Per the Outstanding Equity Awards at Fiscal Year-End table in CATALYST PHARMACEUTICALS, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

8 Form 4 lines since the FY2025 proxy (filed April 30, 2026)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-07-15Disposition to the issuer—2,309$31.500
2026-07-15Disposition to the issuer derivative—98,652$0.000
2026-07-15Disposition to the issuer derivative—29,776$0.000
2026-07-15Disposition to the issuer derivative—124,447$0.000
2026-07-15Disposition to the issuer derivative—12,209$0.000
2026-06-03Exercise or conversion—3,052—3,052
2026-06-03Tax withholding—743—2,309
2025-06-03Exercise or conversion derivative—3,052$0.00240,195

The 8 most recent of 8 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

CATALYST PHARMACEUTICALS’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Richard DalyPresident and CEO$8,177,496
William Andrews · this pageCMO$4,130,549
Steven MillerCOO and CSO$3,691,779
Michael KalbEVP and CFO$3,280,377
Jeffrey Del CarmenCCO$2,784,547

The full CATALYST PHARMACEUTICALS compensation record

free company brief

This page is one person within CATALYST PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CATALYST PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

William Andrews's compensation dossier · One-time report. No refunds.